Sandbox:ap: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 53: | Line 53: | ||
* Hypercalcemia detected on routine biochemical panel | * Hypercalcemia detected on routine biochemical panel | ||
| | | | ||
* | * ↑ PTH | ||
* | * ↑ Ca | ||
* | * ''↓/N phosphate'' | ||
|- | |- | ||
|Secondary hyperparathyroidism | |Secondary hyperparathyroidism | ||
Line 64: | Line 64: | ||
** Vitamin D deficiency | ** Vitamin D deficiency | ||
| | | | ||
* '''↑ | * '''↑''' PTH | ||
* | * '''''↓/'''N'' Ca | ||
* | * ''↑ phosphate'' | ||
|- | |- | ||
|Tertiary hyperparathyroidism | |Tertiary hyperparathyroidism |
Revision as of 18:01, 7 September 2017
There are three types of hyperparathyroidism and should be differentiated between each other. Hyperparathyroidism should be differeniated from other causes of hypercalcemia. Causes of hypercalcemia include:
- Parathyroid related
- Primary hyperparathyroidism
- Typical primary hyperparathyroidism
- Familial hypocalciuric hypercalcemia
- Secondary hyperparathyroidism
- Tertiary hyperparathyroidism
- Primary hyperparathyroidism
- Non-parathyroid related
- Malignancy
- Para-neoplastic syndrome: Parathyroid hormone related peptide
- Hypercalcemia due to bone destruction
- Medication induced
- Thiazide diuretics
- Lithium
- Nutritional
- Milk alkali syndrome
- Vitamin D toxicity
- Granulomatous disease
- Sarcoidosis
- Surgical
- Immobilization
- Malignancy
Hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related to Parathyroid gland | Unrelated to parathyroid gland | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary hyperparathyroidism | Secondary hyperparathyroidism | Tertiary hyperparathyroidism | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Typical primary hyperparathyroidism | Familial hypocalciuric hypercalcemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy | Medication induced | Nutritional | Granulomatous disease | Surgical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Para-neoplastic syndrome: Parathyroid hormone related peptide | Metaplasia: Hypercalcemia due to bone destruction | Thiazide diuretics | Lithium | Milk alkali syndrome | Vitamin D toxicity | Sarcoidosis | Immobilization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential diagnosis
Differential diagnosis fo hyperparathyroidism on the basis of hypercalcemia | ||||
---|---|---|---|---|
Disorder | Mechanism of hypercalcemia | Clinical features | Laboratory findings | |
Hyperparathyroidism | Primary hyperparathyroidism | Increase in secretion of parathyroid hormone (PTH) from a primary process in parathyroid gland. Parathyroid hormone causes increase in serum calcium. |
|
|
Secondary hyperparathyroidism | Increase in secretion of parathyroid hormone from a secondary process. Parathyroid hormone causes increase in serum calcium. |
|
| |
Tertiary hyperparathyroidism | continuous elevation of parathyroid hormone even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium. |
|
||
Malignancy | Para-neplastic syndroms | |||
Hypercalcemia due to bone destruction | ||||
Medication induced | Lithium | |||
Thiazide diuretics | ||||
Nutritional | Milk-alkali syndrome | |||
Vitamin D toxicity | ||||
Granulomatous disease | Sarcoidosis |